{"content":"<li class=\"n-box-item date-title\" data-end=\"1535774399\" data-start=\"1535688000\" data-txt=\"Monday, December 23, 2019\">Friday, August 31, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3387322\" data-ts=\"1535755015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDNA\" target=\"_blank\">CDNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387322-caredxminus-2_1-after-200m-mixed-shelf-50m-share-sale-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CareDx -2.1% after $200M mixed shelf, $50M share sale agreement</a></h4><ul>   <li>CareDx (NASDAQ:<a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a>) has <font color='red'>moved 2.1% lower</font> postmarket, after its filing for a <a href=\"https://seekingalpha.com/filing/4157728\" target=\"_blank\">$200M mixed shelf registration</a> and a sales agreement with Jefferies to <a href=\"https://seekingalpha.com/filing/4157834\" target=\"_blank\">offer up to $50M in shares</a>.</li>    <li>The registration covers the potential offering and sale of common stock, preferred stock, debt securities, warrants, and units.</li>    <li>Net proceeds from the Jefferies sales are earmarked for working capital and general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387322\" data-linked=\"CareDx -2.1% after $200M mixed shelf, $50M share sale agreement\" data-tweet=\"$CDNA - CareDx -2.1% after $200M mixed shelf, $50M share sale agreement https://seekingalpha.com/news/3387322-caredxminus-2_1-after-200m-mixed-shelf-50m-share-sale-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3387322-caredxminus-2_1-after-200m-mixed-shelf-50m-share-sale-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387321\" data-ts=\"1535754360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCYX\" target=\"_blank\">SCYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387321-scynexisminus-2_2-after-175m-mixed-shelf-registration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scynexis -2.2% after $175M mixed shelf registration</a></h4><ul>   <li>Scynexis (NASDAQ:<a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a>) has <font color='red'>moved 2.2% lower</font> postmarket after filing a <a href=\"https://seekingalpha.com/filing/4157721\" target=\"_blank\">$175M mixed shelf registration</a> after hours.</li>    <li>The registration covers common stock, preferred stock, debt securities and warrants that hte company may offer and sell.</li>    <li>Shares closed 1.5% higher during the market session to $1.35.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387321\" data-linked=\"Scynexis -2.2% after $175M mixed shelf registration\" data-tweet=\"$SCYX - Scynexis -2.2% after $175M mixed shelf registration https://seekingalpha.com/news/3387321-scynexisminus-2_2-after-175m-mixed-shelf-registration?source=tweet\" data-url=\"https://seekingalpha.com/news/3387321-scynexisminus-2_2-after-175m-mixed-shelf-registration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387314\" data-ts=\"1535751670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387314-after-hours-gainers-losers-08-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (08/31/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+5.2%</font>. <a href='https://seekingalpha.com/symbol/GMS' title='Gypsum Management and Supply'>GMS</a> <font color='green'>+4.9%</font>. <a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/WRE' title='Washington Real Estate Investment'>WRE</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/LOCO' title='El Pollo Loco Holdings'>LOCO</a> <font color='green'>+3.7%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/PERI' title='Perion Network Ltd.'>PERI</a> <font color='red'>-4.7%</font>. <a href='https://seekingalpha.com/symbol/CEPU' title='Central Puerto S.A. ADR'>CEPU</a> <font color='red'>-3.8%</font>. <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/BYD' title='Boyd Gaming Corporation'>BYD</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='red'>-2.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387314\" data-linked=\"After Hours Gainers / Losers (08/31/2018)\" data-tweet=\"$ASNA $ASNA $GMS - After Hours Gainers / Losers (08/31/2018) https://seekingalpha.com/news/3387314-after-hours-gainers-losers-08-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387314-after-hours-gainers-losers-08-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387307\" data-ts=\"1535749180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387307-virnetx-enters-50m-stock-sales-deal-cowen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX enters $50M stock sales deal with Cowen</a></h4><ul>   <li>Coming off a <a href=\"https://seekingalpha.com/news/3387112-virnetx-plus-35_6-percent-judge-denies-apple-new-trial\" target=\"_blank\">court victory</a> that <font color='green'>boosted its stock 13.6%</font> today, VirnetX Holding Corp. (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a>) has entered into a sales agreement with Cowen to <a href=\"https://seekingalpha.com/filing/4157629\" target=\"_blank\">offer up to $50M in shares</a>.</li>    <li>Proceeds will go to development and marketing of its Gabriel Connection Technology product, along with general purposes (which could include working capital, capex, other expenses and acquisitions).</li>    <li>Shares are <font color='green'>up another 1.5%</font> in after-hours trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387307\" data-linked=\"VirnetX enters $50M stock sales deal with Cowen\" data-tweet=\"$VHC - VirnetX enters $50M stock sales deal with Cowen https://seekingalpha.com/news/3387307-virnetx-enters-50m-stock-sales-deal-cowen?source=tweet\" data-url=\"https://seekingalpha.com/news/3387307-virnetx-enters-50m-stock-sales-deal-cowen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387305\" data-ts=\"1535748814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVRS\" target=\"_blank\">CVRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387305-corindus-vascular-inks-30m-stock-sales-agreement-shares-down-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corindus Vascular inks $30M stock sales agreement; shares down 8% after hours</a></h4><ul><li>Corindus Vascular Robotics (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a>) has closed an <a href=\"https://www.sec.gov/Archives/edgar/data/1528557/000138713118004414/cvrs-8k_083118.htm\" target=\"_blank\">agreement </a>with Cowen and Company for the at-the-market sale of up to $30M of its common stock. Cowen will earn the standard 3% commision for its efforts.</li><li>Shares are down&nbsp;<font color='red'>8%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387305\" data-linked=\"Corindus Vascular inks $30M stock sales agreement; shares down 8% after hours\" data-tweet=\"$CVRS - Corindus Vascular inks $30M stock sales agreement; shares down 8% after hours https://seekingalpha.com/news/3387305-corindus-vascular-inks-30m-stock-sales-agreement-shares-down-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3387305-corindus-vascular-inks-30m-stock-sales-agreement-shares-down-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387282\" data-ts=\"1535745337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387282-net-veteran-look-to-netflix-route-to-solve-social-media-ills\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Net veteran: Look to Netflix as route to solve social media ills</a></h4><ul>   <li>Big tech and social media can begin to fix a rack of problems they've created, Net veteran Jaron Lanier says, by shifting models to <a href=\"https://www.cnbc.com/2018/08/31/jaron-lanier-tech-needs-to-clear-the-trash-out-of-the-internet.html\" target=\"_blank\">make the user the customer</a> rather than the center of a lucrative ad model.</li>    <li>Netflix has pointed the way to that being possible, Lanier -- an Internet pioneer who's now an interdisciplinary scientist for Microsoft (<a href=\"http://seekingalpha.com/symbol/MSFT\" target=\"_blank\">MSFT</a> <font color='green'>+0.3%</font>) -- tells CNBC.</li>    <li>Next week brings another round of visits to Capitol Hill by tech execs: Twitter's (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='red'>-1%</font>) Jack Dorsey is <a href=\"https://seekingalpha.com/news/3385686-house-panel-twitters-dorsey-testify-sept-5\" target=\"_blank\">testifying before House and Senate panels</a>, and Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='red'>-1.1%</font>) COO Sheryl Sandberg is attending the Senate hearing as well, while Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='red'>-1.8%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='red'>-1.8%</font>) CEO Sundar Pichai <a href=\"https://seekingalpha.com/news/3386338-google-ceo-criticized-declining-testify\" target=\"_blank\">looks to be skipping it</a>.</li>    <li>The firms need to become more like \"real businesses where the user is also the customer,\" Lanier says. \"We need to go through that transition to clear the trash out of the Internet.\"</li>    <li>\"It works. Netflix proved it works,\" he says. \"We used to think, 'Oh, nobody will ever pay for a movie online, because you can get them for free.' But actually, if you're willing to pay for them, they get better. You get peak TV.\"</li>    <li>The current ad-supported business model has led in large part to social media being arbiters of speech, a role they're not suited for, he says. \"It's a terrible role. Nobody wants them to have it; they don't want it.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387282\" data-linked=\"Net veteran: Look to Netflix as route to solve social media ills\" data-tweet=\"$GOOG $GOOG $GOOGL - Net veteran: Look to Netflix as route to solve social media ills https://seekingalpha.com/news/3387282-net-veteran-look-to-netflix-route-to-solve-social-media-ills?source=tweet\" data-url=\"https://seekingalpha.com/news/3387282-net-veteran-look-to-netflix-route-to-solve-social-media-ills\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387279\" data-ts=\"1535744926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNS\" target=\"_blank\">ASNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387279-arsanis-up-23\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arsanis up 23%</a></h4><ul><li>Thinly traded nano cap Arsanis (<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='green'>+22.9%</font>) is showing some life on over 5x normal volume. Shares had lost&nbsp;<font color='red'>90%</font>&nbsp;of their value since late June when it <a href=\"https://seekingalpha.com/news/3366796-arsanis-discontinue-phase-2-trial-pneumonia-treatment\" target=\"_blank\">announced </a>that it was terminating a mid-stage study of ASN100 in certain pneumonia patients.</li><li>On the capital front, at the end of June it had $49.9M in cash and equivalents while operations consumed $25.7M in H1. It will need more capital eventually, though. Its next clinical trial, a Phase 1 assessing ASN500 in RSV, won't start until H2 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387279\" data-linked=\"Arsanis up 23%\" data-tweet=\"$ASNS $XFOR - Arsanis up 23% https://seekingalpha.com/news/3387279-arsanis-up-23?source=tweet\" data-url=\"https://seekingalpha.com/news/3387279-arsanis-up-23\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387277\" data-ts=\"1535744174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNT\" target=\"_blank\">INNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387277-innovate-bio-up-29-ahead-of-clinical-update-and-nash-data-release\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Innovate Bio up 29% ahead of clinical update and NASH data release</a></h4><ul><li>Innovate Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='green'>+29.1%</font>) is up almost a 6x surge in volume. The company will host its Clinical and Scientific Update next Thursday, September 6 at 8:15 am ET. It also plans to announce preclinical data on NASH candidate <a href=\"http://www.innovatebiopharma.com/inn-217.html\" target=\"_blank\">INN-217</a> in the coming weeks.</li><li>On the capital front, at the end of June it had $10.7M in cash and equivalents. Operations consumed $9.3M in H1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387277\" data-linked=\"Innovate Bio up 29% ahead of clinical update and NASH data release\" data-tweet=\"$INNT - Innovate Bio up 29% ahead of clinical update and NASH data release https://seekingalpha.com/news/3387277-innovate-bio-up-29-ahead-of-clinical-update-and-nash-data-release?source=tweet\" data-url=\"https://seekingalpha.com/news/3387277-innovate-bio-up-29-ahead-of-clinical-update-and-nash-data-release\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387275\" data-ts=\"1535742974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQST\" target=\"_blank\">AQST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387275-fda-tentatively-oks-aquestives-sympazan-for-severe-type-of-childhood-epilepsy-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA tentatively OKs Aquestive&#39;s Sympazan for severe type of childhood epilepsy; shares up 1%</a></h4><ul><li>Aquestive Therapeutics (<a href='https://seekingalpha.com/symbol/AQST' title='Aquestive Therapeutics'>AQST</a> <font color='green'>+1%</font>) is up on below-average volume on the heels of <a href=\"https://seekingalpha.com/pr/17258673-aquestive-therapeutics-announces-tentative-fda-approval-sympazan-clobazam-oral-film\" target=\"_blank\">tentative FDA approval</a> for Sympazan (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome &#40;LGS&#41;, a severe form of childhood epilepsy, in patients at least two years old.</li><li>Clobazam is currently marketed in tablet and oral suspension formulations by Lundbeck (<a href='https://seekingalpha.com/symbol/HLUKF' title='H. Lundbeck A/S'>OTC:HLUKF</a>)(<a href='https://seekingalpha.com/symbol/HLUYY' title='H. Lundbeck A/S ADR'>OTCPK:HLUYY</a>) under the brand name <a href=\"https://www.onfi.com/\" target=\"_blank\">ONFI</a>.</li><li>The company says its oral film formulation is better suited for LGS sufferers since they often have difficulty swallowing pills or large volume suspensions.</li><li>The FDA nod is tentative to allow for the expiration of Orphan Drug exclusivity for ONFI in October.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387275\" data-linked=\"FDA tentatively OKs Aquestive&#39;s Sympazan for severe type of childhood epilepsy; shares up 1%\" data-tweet=\"$AQST $AQST $HLUKF - FDA tentatively OKs Aquestive&#39;s Sympazan for severe type of childhood epilepsy; shares up 1% https://seekingalpha.com/news/3387275-fda-tentatively-oks-aquestives-sympazan-for-severe-type-of-childhood-epilepsy-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3387275-fda-tentatively-oks-aquestives-sympazan-for-severe-type-of-childhood-epilepsy-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387271\" data-ts=\"1535741722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387271-technology-top-5-gainers-losers-of-2_55-pm-08-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (08/31/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/OIIM' title='O2Micro International Limited'>OIIM</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PAR' title='PAR Technology Corporation'>PAR</a> <font color='green'>+7%</font>.</li>     <li><strong>Losers:</strong>&nbsp;<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3387271\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (08/31/2018)\" data-tweet=\"$VHC $VHC $IDTI - Technology - Top 5 Gainers / Losers as of 2.55 PM (08/31/2018) https://seekingalpha.com/news/3387271-technology-top-5-gainers-losers-of-2_55-pm-08-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387271-technology-top-5-gainers-losers-of-2_55-pm-08-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387269\" data-ts=\"1535741540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387269-brazil-regulator-approves-petrobras-to-restart-replan-refinery\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil regulator approves Petrobras to restart Replan refinery</a></h4><ul><li>Brazil regulator ANP says Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+3.4%</font>) may <a href=\"https://www.ogj.com/articles/2018/08/brazil-s-anp-approves-petrobras-to-restart-replan-refinery.html\" target=\"_blank\">resume production</a> at the 415K bbl/day Replan refinery, following an <a href=\"https://seekingalpha.com/news/3384229-petrobras-says-fire-controlled-biggest-refinery-fuel-supplies-unaffected\" target=\"_blank\">Aug. 20 fire</a> that led to a temporary  suspension of operations at the complex.</li><li>PBR says it expects regularization of the distillation unit  within two days, catalytic cracking and hydrotreatment units within three days and other unaffected units within a week, which would normalize 50%  of the refinery&rsquo;s production within the period.</li><li>The fire was started by an explosion in a tank of one of the  acidic water units associated with the U-220A catalytic cracking unit  that also impacted one of the refinery&rsquo;s atmospheric distillation units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387269\" data-linked=\"Brazil regulator approves Petrobras to restart Replan refinery\" data-tweet=\"$PBR - Brazil regulator approves Petrobras to restart Replan refinery https://seekingalpha.com/news/3387269-brazil-regulator-approves-petrobras-to-restart-replan-refinery?source=tweet\" data-url=\"https://seekingalpha.com/news/3387269-brazil-regulator-approves-petrobras-to-restart-replan-refinery\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387267\" data-ts=\"1535740597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EA\" target=\"_blank\">EA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387267-eaminus-1_7-in-drop-after-strategic-retreat-on-key-shooter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EA -1.7% in further drop after strategic retreat on key shooter</a></h4><ul>   <li>Electronic Arts (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>) is <font color='red'>down 1.7%</font> after BofA Merrill Lynch <a href=\"https://seekingalpha.com/news/3387156-bofaml-steps-ea-sidelines-bookings-revision\" target=\"_blank\">cut its rating to Neutral</a>, a reaction to the company's news that it was <a href=\"https://seekingalpha.com/news/3386880-ea-minus-7_7-percent-bookings-cut-peers-hold-steady\" target=\"_blank\">cutting booking guidance</a> alongside a delay of its highly anticipated <i>Battlefield V</i> shooter.</li>    <li>The new game will be postponed by a month to Nov. 20, getting it out of the October crossfire of competing releases: Activision Blizzard's (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='red'>-2.8%</font>) <i>Call of Duty: Black Ops 4</i> and Take-Two's (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='red'>-0.8%</font>) <i>Red Dead Redemption 2.</i></li>    <li>That push-out of sales is a big part of a $350M year cut to fiscal year bookings expectations. Shares <font color='red'>fell nearly 10%</font> yesterday in response.</li>    <li>The company says it's making \"some final adjustments\" to the game from player testing, and while that means a hit to current-year bookings, <a href=\"https://www.wsj.com/articles/ea-blinks-in-videogame-shooter-standoff-1535645821\" target=\"_blank\">it's the right move</a>, <i>WSJ's</i> Heard on the Street noted. \"The game would have struggled for attention\" with the other two releases, particularly given pent-up demand for the already-delayed <i>RDR 2.</i></li>    <li>\"And today&rsquo;s big games are expected to generate a long tail of revenue through continued player engagement, so getting the details right early matters a lot,\" Dan Gallagher notes. \"Getting them wrong on this game could leave EA seriously wounded.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387122-bofaml-steps-sidelines-activision-blizzard\" target=\"_blank\">BofAML steps to sidelines on Activision Blizzard</a> (Aug. 31 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387267\" data-linked=\"EA -1.7% in further drop after strategic retreat on key shooter\" data-tweet=\"$EA $EA $ATVI - EA -1.7% in further drop after strategic retreat on key shooter https://seekingalpha.com/news/3387267-eaminus-1_7-in-drop-after-strategic-retreat-on-key-shooter?source=tweet\" data-url=\"https://seekingalpha.com/news/3387267-eaminus-1_7-in-drop-after-strategic-retreat-on-key-shooter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387263\" data-ts=\"1535738430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YPF\" target=\"_blank\">YPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387263-energy-materials-top-gainers-losers-of-2-00-pm-08-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (08/31/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YPF' title='YPF Sociedad Anonima'>YPF</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387263\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (08/31/2018)\" data-tweet=\"$YPF $YPF $TAT - Energy/Materials - Top Gainers / Losers as of 2:00 PM (08/31/2018) https://seekingalpha.com/news/3387263-energy-materials-top-gainers-losers-of-2-00-pm-08-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387263-energy-materials-top-gainers-losers-of-2-00-pm-08-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387261\" data-ts=\"1535737324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGUIF\" target=\"_blank\">CGUIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387261-casino-drops-to-22-year-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casino drops to 22-year low</a></h4><ul><li>Casino Guichard-Perrachon (<a href='https://seekingalpha.com/symbol/CGUIF' title='Casino Guichard Perrachon SA'>OTCPK:CGUIF</a>, <a href='https://seekingalpha.com/symbol/CGUSY' title='Casino Guichard Perrachon SA ADR'>OTCPK:CGUSY</a>) tumbled to a 22-year low today in Europe amid the continued weakness in emerging markets, where the company derives a majority of its revenue. Casino has already been on watch due to its dire debt situation.</li><li>There's also a <a href=\"https://twitter.com/muddywatersre/status/1035517698950672384\" target=\"_blank\">revelation</a>&nbsp;today from short-selling firm Muddy Waters that Casino didn't publish financial accounts on time for one it subsidiaries.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387261\" data-linked=\"Casino drops to 22-year low\" data-tweet=\"$CGUIF $CGUIF $CGUSY - Casino drops to 22-year low https://seekingalpha.com/news/3387261-casino-drops-to-22-year-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3387261-casino-drops-to-22-year-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387260\" data-ts=\"1535737312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387260-big-pharma-in-red-after-astrazeneca-lupus-flop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big Pharma in the red after AstraZeneca lupus flop</a></h4><ul><li>Big Pharma is getting roughed up today. This morning, AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='red'>-1.7%</font>) announced that one of its main drivers of expected future growth failed a late-stage lupus study.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>)(<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='red'>-2%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387107-astrazenecas-anifrolumab-flunks-late-stage-lupus-study-shares-1-percent-premarket\" target=\"_blank\">AstraZeneca's anifrolumab flunks late-stage lupus study; shares down 1% premarket</a> (Aug. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387260\" data-linked=\"Big Pharma in the red after AstraZeneca lupus flop\" data-tweet=\"$AZN $AZN $BHC - Big Pharma in the red after AstraZeneca lupus flop https://seekingalpha.com/news/3387260-big-pharma-in-red-after-astrazeneca-lupus-flop?source=tweet\" data-url=\"https://seekingalpha.com/news/3387260-big-pharma-in-red-after-astrazeneca-lupus-flop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387259\" data-ts=\"1535736766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVTA\" target=\"_blank\">NVTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387259-invitae-continues-pre-equity-offering-up-move-shares-ahead-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invitae continues pre-equity offering up move; shares ahead 4%</a></h4><ul><li>Invitae (<a href='https://seekingalpha.com/symbol/NVTA' title='Invitae'>NVTA</a> <font color='green'>+4.4%</font>) is up on modestly higher volume. Shares have rallied over&nbsp;<font color='green'>90%</font>&nbsp;since touching $7.73 on August 7.</li><li>Last week, the SEC declared its registration statement for a <a href=\"https://www.sec.gov/Archives/edgar/data/1501134/000119312518244711/d603530ds3.htm\" target=\"_blank\">$250M mixed shelf offering</a> effective. At the end of June, it had $85.3M in quick assets while operations consumed $58.7M in H1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387259\" data-linked=\"Invitae continues pre-equity offering up move; shares ahead 4%\" data-tweet=\"$NVTA - Invitae continues pre-equity offering up move; shares ahead 4% https://seekingalpha.com/news/3387259-invitae-continues-pre-equity-offering-up-move-shares-ahead-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3387259-invitae-continues-pre-equity-offering-up-move-shares-ahead-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387254\" data-ts=\"1535735553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAHO\" target=\"_blank\">TAHO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387254-tahoe-resources-suspends-mining-ops-peru-gold-mine-after-protest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tahoe Resources suspends mining ops at Peru gold mine after protest</a></h4><ul>     <li>Tahoe Resources (<a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='red'>-2.7%</font>) says it has <a href=\"https://www.reuters.com/article/us-tahoe-resources-protest-peru/tahoe-suspends-mining-at-peru-operation-after-protest-idUSKCN1LG21G\" target=\"_blank\">temporarily suspended mining operations</a> at its La Arena gold mine in Peru after protesters trespassed on its property and demanded payment for environmental impacts of mining.</li>     <li>The protest followed recent meetings between Tahoe and residents from the nearby community of La Ramada who say they want compensation for unspecified damage caused by dust and vibrations from blasting at the mine; the company says the mine blasting complies with the law and environmental quality standards.</li>     <li>Earlier this week, Tahoe said ~600 cm of cyanide and gold bearing solution may have leaked from the mine site into a neighboring creek, caused by an apparent theft attempt.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387254\" data-linked=\"Tahoe Resources suspends mining ops at Peru gold mine after protest\" data-tweet=\"$TAHO - Tahoe Resources suspends mining ops at Peru gold mine after protest https://seekingalpha.com/news/3387254-tahoe-resources-suspends-mining-ops-peru-gold-mine-after-protest?source=tweet\" data-url=\"https://seekingalpha.com/news/3387254-tahoe-resources-suspends-mining-ops-peru-gold-mine-after-protest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387249\" data-ts=\"1535734835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GGAL\" target=\"_blank\">GGAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387249-financials-top-gainers-losers-of-1-00-pm-08-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (08/31/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francés S.A.  ADR'>BFR</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387249\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (08/31/2018)\" data-tweet=\"$GGAL $GGAL $BMA - Financials - Top Gainers / Losers as of 1:00 PM (08/31/2018) https://seekingalpha.com/news/3387249-financials-top-gainers-losers-of-1-00-pm-08-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387249-financials-top-gainers-losers-of-1-00-pm-08-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387248\" data-ts=\"1535734794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387248-u-s-senate-postpones-postal-service-hearing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Senate postpones Postal Service hearing</a></h4><ul><li>        A Senate hearing about reforming the U.S. Postal Service has been delayed, according to <a href=\"https://www.reuters.com/article/us-usa-post-office-amazon-com/senate-cancels-postal-service-hearing-trumps-amazon-crusade-delayed-idUSKCN1LG28O\" target=\"_blank\">Reuters sources</a>.</li><li>               President Trump ordered a task force to study the Postal Service&rsquo;s financial health and what it charges customers like Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+0.5%</font>) for delivering packages.&nbsp;</li><li>               The study was ordered with the report release set for August 10. The White House hasn&rsquo;t yet released the report, forcing the Senate to delay its reform hearing scheduled for September 5.&nbsp;</li><li>               The Postal Service is an independent establishment of the U.S. executive branch. &nbsp;FY17 revenue <a href=\"https://about.usps.com/news/national-releases/2017/pr17_069.htm\" target=\"_blank\">was down</a> $1.8B Y/Y to $69.6B with $72.2B in operating expenses. The drop was due to declines in First-Class and Marketing Mail, partially offset by an 11% growth in package volume.&nbsp;</li><li>               Stamps.com (NASDAQ:<a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a>) shares are<font color='green'> up 1.4%</font>&nbsp;after the news.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320429-trump-slams-amazon-calling-higher-post-office-pricing\" target=\"_blank\">Trump slams Amazon while calling for higher Post Office pricing</a> (Dec. 29, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387248\" data-linked=\"U.S. Senate postpones Postal Service hearing\" data-tweet=\"$AMZN $AMZN $STMP - U.S. Senate postpones Postal Service hearing https://seekingalpha.com/news/3387248-u-s-senate-postpones-postal-service-hearing?source=tweet\" data-url=\"https://seekingalpha.com/news/3387248-u-s-senate-postpones-postal-service-hearing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387240\" data-ts=\"1535733731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387240-midday-gainers-losers-08-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (08/31/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/PDEX' title='Pro-Dex, Inc.'>PDEX</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+19%</font>. TPIV <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/EDN' title='Empresa Distribuidora y Comercializadora Norte S.A.'>EDN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+16%</font>.</li>     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited ADR'>IMMP</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MKGI' title='Monaker Group, Inc.'>MKGI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PHII' title='PHI, Inc.'>PHII</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3387240\" data-linked=\"Midday Gainers / Losers (08/31/2018)\" data-tweet=\"$AOBC $AOBC $PDEX - Midday Gainers / Losers (08/31/2018) https://seekingalpha.com/news/3387240-midday-gainers-losers-08-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387240-midday-gainers-losers-08-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387235\" data-ts=\"1535732295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVE\" target=\"_blank\">CVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387235-canadian-oil-firms-add-to-losses-after-court-blocks-trans-mountain-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian oil firms add to losses after court blocks Trans Mountain project</a></h4><ul>     <li>Most oil-weighted Canadian energy stocks extend yesterday's losses after an appeals court <a href=\"https://seekingalpha.com/news/3386913-trans-mountain-project-approvals-nullified-canadian-appeals-court\" target=\"_blank\">annulled regulatory approval</a> of the Trans Mountain pipeline expansion project, <a href=\"https://business.financialpost.com/commodities/tide-of-investment-set-to-recede-from-oilpatch-amid-more-pipeline-delays\" target=\"_blank\">raising new alarms</a> over Canada&rsquo;s regulatory system and threatening to scare off would-be investors in large-scale projects in the country.</li>     <li>Most oil-weighted Canadian energy stocks fell on the news, and some continue to lose ground today: <a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-2.8%</font> after shedding nearly 2% yesterday, <a href='https://seekingalpha.com/symbol/CNQ' title='Canadian Natural Resources, Ltd.'>CNQ</a> <font color='red'>-2.3%</font> after falling 1.2%, <a href='https://seekingalpha.com/symbol/SU' title='Suncor Energy Inc.'>SU</a> <font color='red'>-0.5%</font> following a slight gain yesterday, and <a href='https://seekingalpha.com/symbol/MEGEF' title='Meg Energy Corp.'>OTCPK:MEGEF</a> edges into the green after a nearly 4% drop yesterday.</li>     <li>&ldquo;After years of exhaustive review, any further delays to this important project will only serve to harm the Canadian economy by limiting access to global markets for the country&rsquo;s oil exports and depriving  governments of additional tax and royalty revenues,\"&nbsp;CVE says.</li>     <li>The amount of crude oil moving on railway cars will <a href=\"https://business.financialpost.com/commodities/energy/trans-mountain-pipeline-approval-quashed-by-court\" target=\"_blank\">continue to grow without new export pipelines</a>, as the current export system is full and in apportionment, according to Scotiabank's Rory Johnston, saying &ldquo;You need two of the three [currently proposed pipelines] to clear our egress issues,\" referring to the Trans Mountain expansion, Enbridge&rsquo;s (<a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color='red'>-1.8%</font>) Line 3 project and TransCanada&rsquo;s (<a href='https://seekingalpha.com/symbol/TRP' title='TransCanada Corporation'>TRP</a> <font color='red'>-1.7%</font>) Keystone XL  project.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387235\" data-linked=\"Canadian oil firms add to losses after court blocks Trans Mountain project\" data-tweet=\"$CVE $CVE $CNQ - Canadian oil firms add to losses after court blocks Trans Mountain project https://seekingalpha.com/news/3387235-canadian-oil-firms-add-to-losses-after-court-blocks-trans-mountain-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3387235-canadian-oil-firms-add-to-losses-after-court-blocks-trans-mountain-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387232\" data-ts=\"1535731621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICLQY\" target=\"_blank\">ICLQY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387232-merged-vodafone-idea-takes-over-indias-top-carrier\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merged Vodafone Idea takes over as India&#39;s top carrier</a></h4><ul>   <li>A now-closed merger between Vodafone India (<a href=\"http://seekingalpha.com/symbol/VOD\" target=\"_blank\">VOD</a> <font color='red'>-1.6%</font>) and Idea Cellular (<a href='https://seekingalpha.com/symbol/ICLQY' title='Idea Cellular Ltd. ADR'>OTC:ICLQY</a>) has established Vodafone Idea, <a href=\"https://www.lightreading.com/services/mobile-services/vodafone-idea-is-born-topples-airtel-to-become-indias--1-service-provider/d/d-id/745771?_mc=RSS_LR_EDT\" target=\"_blank\">now the No. 1 service provider in India</a>.</li>    <li>The new entity has 408M active mobile subscribers, topping Bharti Airtel (<a href='https://seekingalpha.com/symbol/BHRQY' title='BHARTI AIRTEL LTD ADR'>OTCPK:BHRQY</a>) as the biggest provider by user numbers.</li>    <li>The two had market shares of 19.4% and 19.2% respectively, now combined to nearly 39% of active mobile connections.</li>    <li>They make up about 32% of the revenues in the market as well, having combined for 585B rupees (about $8.26B) in the 12 months ended June 30.</li>    <li>The huge India market has about 1.15B mobile connections.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3386942-vodafone-tpg-merge-australian-operations\" target=\"_blank\">Vodafone, TPG to merge Australian operations</a> (Aug. 30 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3386844-vodafone-minus-2_9-percent-bofaml-drops-neutral-stance-headwinds\" target=\"_blank\">Vodafone -2.9% as BofAML drops to Neutral stance on headwinds</a> (Aug. 30 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372613-vodafone-india-idea-make-deposit-clear-merger-path\" target=\"_blank\">Vodafone India, Idea make deposit to clear merger path</a> (Jul. 23 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387232\" data-linked=\"Merged Vodafone Idea takes over as India&#39;s top carrier\" data-tweet=\"$ICLQY $ICLQY $BHRQY - Merged Vodafone Idea takes over as India&#39;s top carrier https://seekingalpha.com/news/3387232-merged-vodafone-idea-takes-over-indias-top-carrier?source=tweet\" data-url=\"https://seekingalpha.com/news/3387232-merged-vodafone-idea-takes-over-indias-top-carrier\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387229\" data-ts=\"1535731225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387229-consumer-top-gainers-losers-of-12-00-pm-08-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer- Top Gainers / Losers as of 12:00 PM (08/31/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+16%</font>. AOI <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SUMR' title='Summer Infant, Inc.'>SUMR</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/CRESY' title='Cresud S.A.C.I.F. y A.'>CRESY</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-17%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387229\" data-linked=\"Consumer- Top Gainers / Losers as of 12:00 PM (08/31/2018)\" data-tweet=\"$LULU $LULU $PYX - Consumer- Top Gainers / Losers as of 12:00 PM (08/31/2018) https://seekingalpha.com/news/3387229-consumer-top-gainers-losers-of-12-00-pm-08-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387229-consumer-top-gainers-losers-of-12-00-pm-08-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387227\" data-ts=\"1535730536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387227-california-lawmakers-set-to-decide-whether-pg-and-e-too-big-to-fail\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">California lawmakers set to decide whether PG&amp;E &#39;too big to fail&#39;</a></h4><ul>     <li><a href=\"https://www.bloomberg.com/news/articles/2018-08-31/california-is-set-to-decide-whether-pg-e-is-too-big-to-fail\" target=\"_blank\">California legislators have until midnight tonight</a> to pass a bill that would cap the amount PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-1.9%</font>) must pay related to the 2017 wine country fires, amid concerns that massive fire claims could force the company into financial distress or bankruptcy.</li>     <li>PG&amp;E shares have climbed nearly 10% this week as details emerged on draft legislation that would direct regulators to conduct a stress test to determine how much PG&amp;E can pay for the 2017 fires \"without harming ratepayers and materially impacting its ability to provide adequate and safe service,\" and the utility could cover the costs of anything above that amount by selling bonds backed by fixed customer rates.</li>     <li>The provision takes \"bankruptcy off the table,&rdquo; says CreditSights analyst Andy DeVries, but the bill still \"leaves significant uncertainty for investors\" as it will be up to state regulators to decide how much PG&amp;E pays.</li>     <li>&ldquo;This is the state acting like PG&amp;E is too big to fail,&rdquo; says Mark Toney of the Utility Reform Network. &ldquo;They want to make sure PG&amp;E has a guaranteed backstop no matter how badly they operate.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3387227\" data-linked=\"California lawmakers set to decide whether PG&amp;E &#39;too big to fail&#39;\" data-tweet=\"$PCG - California lawmakers set to decide whether PG&amp;E &#39;too big to fail&#39; https://seekingalpha.com/news/3387227-california-lawmakers-set-to-decide-whether-pg-and-e-too-big-to-fail?source=tweet\" data-url=\"https://seekingalpha.com/news/3387227-california-lawmakers-set-to-decide-whether-pg-and-e-too-big-to-fail\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387224\" data-ts=\"1535730182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387224-catalyst-pharma-perks-up-ahead-of-fda-action-on-firdapse-for-lems-shares-ahead-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma perks up ahead of FDA action on Firdapse for LEMS; shares ahead 8%</a></h4><ul><li>Catalyst Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color='green'>+7.6%</font>) is up on average volume. Shares have perked up&nbsp;<font color='green'>20%</font>&nbsp;since touching $2.70 on August 8.</li><li>November 28 is the FDA's <a href=\"https://seekingalpha.com/news/3359908-fda-accepts-catalysts-nda-priority-review-status-firdapse-lems\" target=\"_blank\">action date</a> for its marketing application seeking approval for Firdapse for the treatment of an autoimmune disorder called <a href=\"https://www.mda.org/disease/lambert-eaton-myasthenic-syndrome\" target=\"_blank\">Lambert-Eaton myasthenic syndrome</a> &#40;LEMS&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387224\" data-linked=\"Catalyst Pharma perks up ahead of FDA action on Firdapse for LEMS; shares ahead 8%\" data-tweet=\"$CPRX - Catalyst Pharma perks up ahead of FDA action on Firdapse for LEMS; shares ahead 8% https://seekingalpha.com/news/3387224-catalyst-pharma-perks-up-ahead-of-fda-action-on-firdapse-for-lems-shares-ahead-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3387224-catalyst-pharma-perks-up-ahead-of-fda-action-on-firdapse-for-lems-shares-ahead-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387222\" data-ts=\"1535729576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387222-profit-taking-pressures-insys-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Profit-taking pressures Insys, down 14%</a></h4><ul><li>INSYS Therapeutics (<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-13.6%</font>) slumps on more than a 4x surge in volume as investors take money off the table after yesterday's&nbsp;<font color='green'>34%&nbsp;</font>spike after it <a href=\"https://seekingalpha.com/news/3386722-fda-grants-insys-therapeutics-fast-track-designation-epinephrine-nasal-spray\" target=\"_blank\">announced </a>Fast Track status for its epinephrine nasal spray for the emergency treatment of severe allergic reactions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387222\" data-linked=\"Profit-taking pressures Insys, down 14%\" data-tweet=\"$INSY $INSYQ - Profit-taking pressures Insys, down 14% https://seekingalpha.com/news/3387222-profit-taking-pressures-insys-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3387222-profit-taking-pressures-insys-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387221\" data-ts=\"1535729378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387221-twitter-launches-issue-ad-hurdles-exempting-news-media\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter launches issue-ad hurdles, exempting news media</a></h4><ul>   <li>A new <a href=\"https://blog.twitter.com/official/en_us/topics/company/2018/Announcing-new-US-issue-ads-policy.html\" target=\"_blank\">policy on issue ads</a> on Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='red'>-2.2%</font>) calls for extra steps from those who want to place advertisements tied to politically charged topics, but <a href=\"https://media.twitter.com/en_us/articles/generic/issue-ads-policy--what-this-means-for-news-organizations.html\" target=\"_blank\">exempts news organizations</a> that want to promote news stories on the issues.</li>    <li>The new policy affects ads that refer to an election or clearly identified candidate, or to advocacy for legislative issues of national importance -- like \"abortion, civil rights, climate change, guns, healthcare, immigration, national security, social security, taxes, and trade,\" Twitter says.</li>    <li>Advertisers will need to get certified as to their identity and location within the United States under the new policy, and meet specific eligibility requirements.</li>    <li>But news organizations that want to promote links to key stories that happen to hit those issues will be exempted from the extra hurdles: \"We don&rsquo;t believe that news organizations running ads on Twitter that report on these issues, rather than advocate for or against them, should be subject to this policy.\"</li>    <li>To qualify, news orgs will have to have at least 200,000 monthly unique visitors in the U.S. and met certain other transparency standards (contact/about information available online, as well as info on dedicated reporter/editorial staff; a searchable archive online; and not being a single-issue site or primarily user-generated or aggregated).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387221\" data-linked=\"Twitter launches issue-ad hurdles, exempting news media\" data-tweet=\"$TWTR - Twitter launches issue-ad hurdles, exempting news media https://seekingalpha.com/news/3387221-twitter-launches-issue-ad-hurdles-exempting-news-media?source=tweet\" data-url=\"https://seekingalpha.com/news/3387221-twitter-launches-issue-ad-hurdles-exempting-news-media\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387220\" data-ts=\"1535729185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDEX\" target=\"_blank\">PDEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387220-pro-dex-up-21-following-fq4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pro-Dex up 21% following FQ4 results</a></h4><ul><li>Ultra-thinly traded nano cap Pro-Dex (<a href='https://seekingalpha.com/symbol/PDEX' title='Pro-Dex, Inc.'>PDEX</a> <font color='green'>+21.1%</font>) is up on almost a 14x surge in volume, albeit on turnover of only 90K shares, on the heels of its <a href=\"http://www.irdirect.net/prviewer/release/id/3282931\" target=\"_blank\">release </a>of fiscal Q4 and fiscal 2018 results.</li><li>FQ4 sales increased 12% to $6.2M with net income down 77% to $168K.</li><li>Fiscal 2018 sales were up 2% to $22.5M. Net income was $1.6M, down 67% from a year ago. A contributing factor was the write-down of its entire $800K investment in Monogram Orthopaedics.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387220\" data-linked=\"Pro-Dex up 21% following FQ4 results\" data-tweet=\"$PDEX - Pro-Dex up 21% following FQ4 results https://seekingalpha.com/news/3387220-pro-dex-up-21-following-fq4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3387220-pro-dex-up-21-following-fq4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387215\" data-ts=\"1535728459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVVC\" target=\"_blank\">SVVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387215-firsthand-technology-value-fund-adopts-share-repurchase-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firsthand Technology Value fund adopts share repurchase plan</a></h4><ul>     <li>Firsthand Technology Value Fund's (<a href='https://seekingalpha.com/symbol/SVVC' title='Firsthand Technology Value Fund'>SVVC</a> <font color='green'>+4.7%</font>) Board of Directors has approved a discretionary share repurchase plan.</li>     <li>The Fund may purchase in the open market up to $2M worth of its common stock.</li>     <li>The Fund expects the Plan will be in effect until March 31, 2019, or until the approved dollar amount has been used to repurchase shares.</li>     <li>Firsthand&rsquo;s CEO, Kevin Landis, has announced his own intention to purchase up to $1M worth of stock, either directly or indirectly.</li><li><a href=\"https://seekingalpha.com/pr/17258528-firsthand-technology-value-fund-adopts-share-repurchase-plan\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3387215\" data-linked=\"Firsthand Technology Value fund adopts share repurchase plan\" data-tweet=\"$SVVC - Firsthand Technology Value fund adopts share repurchase plan https://seekingalpha.com/news/3387215-firsthand-technology-value-fund-adopts-share-repurchase-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3387215-firsthand-technology-value-fund-adopts-share-repurchase-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387209\" data-ts=\"1535727640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDEX\" target=\"_blank\">PDEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387209-healthcare-top-5-gainers-losers-of-11-00-08-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (08/31/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PDEX' title='Pro-Dex, Inc.'>PDEX</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387209\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (08/31/2018)\" data-tweet=\"$PDEX $PDEX $EVFM - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (08/31/2018) https://seekingalpha.com/news/3387209-healthcare-top-5-gainers-losers-of-11-00-08-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387209-healthcare-top-5-gainers-losers-of-11-00-08-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387207\" data-ts=\"1535727270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387207-wolfe-research-highlights-long-term-case-on-lululemon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wolfe Research highlights long-term case on Lululemon</a></h4><ul><li>Wolfe Research stays positive on Lululemon (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+14.7%</font>) even after the monster 99% YTD run for shares.</li><li>The analyst team calls out the \"flawless execution\" in Q2, while also looking at the long-term potential for LULU. In particular, Wolfe points to the company's successful omnichannel model defined by accretive, non-cannibalizing e-commerce growth, the China/Asia-specific growth and brand resonance with the fast-growing Millennial generation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387207\" data-linked=\"Wolfe Research highlights long-term case on Lululemon\" data-tweet=\"$LULU - Wolfe Research highlights long-term case on Lululemon https://seekingalpha.com/news/3387207-wolfe-research-highlights-long-term-case-on-lululemon?source=tweet\" data-url=\"https://seekingalpha.com/news/3387207-wolfe-research-highlights-long-term-case-on-lululemon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387202\" data-ts=\"1535726178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387202-abercrombie-fitch-peels-off-another-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp; Fitch peels off another 6%</a></h4><ul><li>Abercrombie &amp; Fitch (NYSE:<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a>) is&nbsp;<font color='red'>down 6.2%</font>&nbsp;in a second straight day of selling pressure after the retailer's earnings disappointed.</li><li>Morgan Stanley added to the negative sentiment this morning, with a warning that A&amp;F's domestic sales comparables in upcoming quarters will be tough to match.</li><li>Morgan Stanley has Abercrombie &amp; Fitch rated at Underweight and assigned a price target of $14 to rep 36% downside potential.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3386794-investors-push-abercrombie-and-fitch-back-earnings\" target=\"_blank\">Investors push Abercrombie &amp; Fitch back down after earnings</a> (Aug. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387202\" data-linked=\"Abercrombie &amp; Fitch peels off another 6%\" data-tweet=\"$ANF - Abercrombie &amp; Fitch peels off another 6% https://seekingalpha.com/news/3387202-abercrombie-fitch-peels-off-another-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3387202-abercrombie-fitch-peels-off-another-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387200\" data-ts=\"1535725726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAGS\" target=\"_blank\">PAGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387200-pagseguro-digital-up-12_6-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PagSeguro Digital up 12.6% post Q2 results</a></h4><ul><li>PagSeguro Digital (<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a> <font color='green'>+12.6%</font>) <a href=\"http://investors.pagseguro.com/Cache/1001242660.PDF?O=PDF&amp;T=&amp;Y=&amp;D=&amp;FID=1001242660&amp;iid=9282297\" target=\"_blank\">reports Q2</a> Non-GAAP revenue growth of 74.9% Y/Y to R$974.5M.</li><li>Total payment volume up 106.8% Y/Y to R$16.9B.</li><li>Active merchants in the last 12 months at close of period of 3.5M, up 68.7%Y/Y, with growth of 1.4M net new merchants.</li><li>Non-GAAP net income of R$242.1M.</li><li>Net Margin of 22.7% up 790 bps &amp; Non-GAAP Net Margin of 24.8%.</li><li>Cash and equivalents amounted to R$2.91B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387024-pagseguro-beats-r-0_06-beats-revenue\" target=\"_blank\">PagSeguro beats by R$0.06, beats on revenue</a> (Aug. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387200\" data-linked=\"PagSeguro Digital up 12.6% post Q2 results\" data-tweet=\"$PAGS - PagSeguro Digital up 12.6% post Q2 results https://seekingalpha.com/news/3387200-pagseguro-digital-up-12_6-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3387200-pagseguro-digital-up-12_6-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387197\" data-ts=\"1535725178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCINF\" target=\"_blank\">OCINF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387197-on-ocis-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on OCI&#39;s Q2 results</a></h4><ul><li>OCI (<a href='https://seekingalpha.com/symbol/OCINF' title='OCI N.V.'>OTC:OCINF</a>) <a href=\"http://www.oci.nl/media/cms_page_media/2018/8/31/OCI%20N.V.%20H1%202018%20Results%20Report.pdf\" target=\"_blank\">reported Q2</a> sales growth of 43.4% Y/Y to $792.7M due to increase in volumes and on average higher realized selling prices.</li><li>Total sales volumes 2.81M (+46% Y/Y) metric tons, with OCI product at 2.46M (+47% Y/Y) metric tons and Third party traded at 386k (+41% Y/Y) metric ton.</li><li>On an average 2Q18 saw higher realized selling prices for all products except ammonia compared to 2Q17, but lower compared to the 1Q18.</li><li>Q2 Gross margin<font color='green'> improved by 365 bps</font>&nbsp;to 20.2%.</li><li>EBITDA increased by 92% Y/Y to $215M and Adj. EBITDA increased by 22% Y/Y to $204M.</li><li>Q2 Free cash flow $133.3M compared to $49.5M a year ago.</li><li>Net debt was $4.3B as of June 30, 2018, compared to $4.4B in last quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387126-oci-n-v-reports-q2-results\" target=\"_blank\">OCI N.V. reports Q2 results</a> (Aug. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387197\" data-linked=\"More on OCI&#39;s Q2 results\" data-tweet=\"$OCINF - More on OCI&#39;s Q2 results https://seekingalpha.com/news/3387197-on-ocis-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3387197-on-ocis-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387198\" data-ts=\"1535725009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387198-yandex-tops-google-in-android-search-share-in-russia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yandex tops Google in Android search share in Russia</a></h4><ul>   <li>Data gathered by Yandex.Radar shows that its parent search engine (<a href=\"http://seekingalpha.com/symbol/YNDX\" target=\"_blank\">YNDX</a> <font color='green'>+2.1%</font>) has for the first time taken a higher share of Web searches on Android devices in Russia than Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='red'>-0.4%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='red'>-0.4%</font>).</li>    <li>Share of searches hit 49.35% during the week of Aug. 13, Yandex says, vs. Google's 49.28%.</li>    <li>That compares to overall share (including desktop) where Yandex accounts for 56% of searches vs. Google's 40%.</li>    <li>Yandex credits the Android shift to pre-installs on Android devices, along with its new voice assistant and marketing efforts.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387198\" data-linked=\"Yandex tops Google in Android search share in Russia\" data-tweet=\"$GOOG $GOOG $GOOGL - Yandex tops Google in Android search share in Russia https://seekingalpha.com/news/3387198-yandex-tops-google-in-android-search-share-in-russia?source=tweet\" data-url=\"https://seekingalpha.com/news/3387198-yandex-tops-google-in-android-search-share-in-russia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387195\" data-ts=\"1535724655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLYS\" target=\"_blank\">TLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387195-post-earnings-rally-continues-for-tillys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings rally continues for Tilly&#39;s</a></h4><ul><li>Shares of Tilly's (NYSE:<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a>) are&nbsp;<font color='green'>up another 7.9%</font>&nbsp;to follow on yesterday's post-earnings spike.</li><li>Tilly's traded at a new 52-week high of $22.32 earlier this morning and is up 28% for the week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3386788-tillys-plus-16-percent-strong-earnings\" target=\"_blank\">Tilly's +16% after strong earnings</a> (Aug. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387195\" data-linked=\"Post-earnings rally continues for Tilly&#39;s\" data-tweet=\"$TLYS - Post-earnings rally continues for Tilly&#39;s https://seekingalpha.com/news/3387195-post-earnings-rally-continues-for-tillys?source=tweet\" data-url=\"https://seekingalpha.com/news/3387195-post-earnings-rally-continues-for-tillys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387190\" data-ts=\"1535724035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPS\" target=\"_blank\">CPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387190-auto-parts-sector-on-watch-after-latest-tariff-developments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto parts sector on watch after latest tariff developments</a></h4><ul><li>The latest tariff threats from President Trump has led to a minor bit of selling in the auto parts sector on concerns of an extended negotiating period.</li><li>Names showing some sensitivity to tariff developments include Cooper-Standard (<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a> <font color='red'>-0.4%</font>), Superior Industries (<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International Inc.'>SUP</a> <font color='red'>-0.7%</font>), Tenneco (<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a> <font color='red'>-0.1%</font>), Delphi Automotive (<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a> <font color='red'>-0.6%</font>), American Axle &amp; Manufacturing (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='red'>-0.6%</font>), Tower International (<a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a> <font color='red'>-0.9%</font>), BorgWarner (<a href='https://seekingalpha.com/symbol/BWA' title='BorgWarner Inc.'>BWA</a> <font color='red'>-0.3%</font>) and Modine Manufacturing (<a href='https://seekingalpha.com/symbol/MOD' title='Modine Manufacturing Company'>MOD</a> <font color='red'>-0.6%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387066-trump-rejects-eu-offer-auto-tariffs\" target=\"_blank\">Trump rejects EU offer on auto tariffs</a> (Aug. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387190\" data-linked=\"Auto parts sector on watch after latest tariff developments\" data-tweet=\"$CPS $CPS $SUP - Auto parts sector on watch after latest tariff developments https://seekingalpha.com/news/3387190-auto-parts-sector-on-watch-after-latest-tariff-developments?source=tweet\" data-url=\"https://seekingalpha.com/news/3387190-auto-parts-sector-on-watch-after-latest-tariff-developments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387186\" data-ts=\"1535723427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387186-ulta-beautyplus-9-on-kylie-jenner-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ulta Beauty +9% on Kylie Jenner buzz</a></h4><ul><li>Ulta Beauty (NASDAQ:<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a>) has come storming back with a&nbsp;<font color='green'>8.8% jump</font>&nbsp;after initially showing a post-earnings decline.</li><li>The retailer broke some news during its earnings call conference (<a href=\"https://seekingalpha.com/article/4203333-ulta-beauty-inc-ulta-ceo-mary-dillon-q2-2018-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>) by confirming a partership with Kylie Jenner to&nbsp;launch in all stores and online later this year.</li><li>CEO Mary Dillon: \"Kylie Jenner is a highly influential force in the beauty industry. This brand addition is yet another example of successful digitally-native brands valuing a brick-and-mortar partnership with Ulta Beauty to extend their reach with consumers. We&rsquo;ll share more details about this launch at a later date.\"</li><li>On her end of the marketing, <a href=\"https://twitter.com/KylieJenner/status/1035262385647366144\" target=\"_blank\">Kylie Jenner</a> generated 14K retweets and 94K likes from her tweet on the partnership.</li><li>Goldman Sachs is out early with a note on the development, saying the Kylie deal has the potential to move the needle for Ulta.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387013-ulta-minus-5_9-percent-q2-beat-holds-downbeat-guidance\" target=\"_blank\">Ulta -5.9% as Q2 beat holds downbeat guidance</a> (Aug. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387186\" data-linked=\"Ulta Beauty +9% on Kylie Jenner buzz\" data-tweet=\"$ULTA - Ulta Beauty +9% on Kylie Jenner buzz https://seekingalpha.com/news/3387186-ulta-beautyplus-9-on-kylie-jenner-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3387186-ulta-beautyplus-9-on-kylie-jenner-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387177\" data-ts=\"1535721887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FENG\" target=\"_blank\">FENG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387177-phoenix-new-mediaplus-2_1-after-first-shanghai-raises-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phoenix New Media +2.1% after First Shanghai raises to Buy</a></h4><ul>   <li>Phoenix New Media ADRs (NYSE:<a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a>) are <font color='green'>up 2.1%</font> in premarket NYSE trading after a raise to Buy by First Shanghai Securities.</li>    <li>The firm updated its price target lower to $5.95 from $6.25, implying 21% upside but on the low side of targets.</li>    <li>The ADRs are <font color='green'>up 14.7%</font> this month, but <font color='red'>down 10.2%</font> overall over the past three months and <font color='red'>down 24.4%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387177\" data-linked=\"Phoenix New Media +2.1% after First Shanghai raises to Buy\" data-tweet=\"$FENG - Phoenix New Media +2.1% after First Shanghai raises to Buy https://seekingalpha.com/news/3387177-phoenix-new-mediaplus-2_1-after-first-shanghai-raises-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3387177-phoenix-new-mediaplus-2_1-after-first-shanghai-raises-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387170\" data-ts=\"1535721173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387170-portola-pharma-files-u-s-application-for-gen-2-andexxa-manufacturing-process-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Portola Pharma files U.S. application for Gen 2 Andexxa manufacturing process; shares up 2% premarket</a></h4><ul><li>Portola Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals'>PTLA</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17258459-portola-pharmaceuticals-submits-prior-approval-supplement-u-s-fda-large-scale-generation-2\" target=\"_blank\">announcement </a>that it has submitted a prior approval supplement &#40;PAS&#41; to the FDA seeking sign-off on its large-scale Generation 2 manufacturing process for anticoagulant reversal agent Andexxa (coagulation factor Xa [recombinant], inactivated-zhzo). The company says the PAS will allow for the broad commercial launch of the product in the U.S. The FDA should make its decision no later than Q1 2019.</li><li>In Europe, Portola says the advisory group CHMP should render an opinion on approval next quarter and, if positive, market approval will follow in Q1 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387170\" data-linked=\"Portola Pharma files U.S. application for Gen 2 Andexxa manufacturing process; shares up 2% premarket\" data-tweet=\"$PTLA - Portola Pharma files U.S. application for Gen 2 Andexxa manufacturing process; shares up 2% premarket https://seekingalpha.com/news/3387170-portola-pharma-files-u-s-application-for-gen-2-andexxa-manufacturing-process-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3387170-portola-pharma-files-u-s-application-for-gen-2-andexxa-manufacturing-process-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387169\" data-ts=\"1535720951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUO\" target=\"_blank\">ZUO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387169-premarket-losers-of-9-05-8-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (8/31/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a>&nbsp;<font color='red'>-18%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3387002-zuora-beats-0_03-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3386986-ambarella-beats-0_12-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='red'>-12%</font>.</li><li><a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3387090-big-lots-misses-0_08-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387169\" data-linked=\"Premarket Losers as of 9:05 am (8/31/2018)\" data-tweet=\"$ZUO $ZUO $AMBA - Premarket Losers as of 9:05 am (8/31/2018) https://seekingalpha.com/news/3387169-premarket-losers-of-9-05-8-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387169-premarket-losers-of-9-05-8-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387168\" data-ts=\"1535720919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387168-premarket-gainers-of-9-05-08-31-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (08/31/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+25%</font>&nbsp;after judge <a href=\"https://seekingalpha.com/news/3387112-virnetx-plus-35_6-percent-judge-denies-apple-new-trial\" target=\"_blank\">denies</a> Apple a new trial.</li>     <li><a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='green'>+21%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3386990-american-outdoor-brands-beats-0_09-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a> <font color='green'>+12%</font>&nbsp;as&nbsp;Renesas Electronics wants to <a href=\"https://seekingalpha.com/news/3387117-nar-renesas-wants-buy-idt-6b-idt-plus-15-percent\" target=\"_blank\">acquire</a> IDT in an over $6B deal.</li>     <li><a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+11%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3386988-lululemon-athletica-beats-0_22-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3387168\" data-linked=\"Premarket Gainers as of 9:05 am (08/31/2018)\" data-tweet=\"$VHC $VHC $AOBC - Premarket Gainers as of 9:05 am (08/31/2018) https://seekingalpha.com/news/3387168-premarket-gainers-of-9-05-08-31-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3387168-premarket-gainers-of-9-05-08-31-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387164\" data-ts=\"1535720563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387164-goodyear-tire-rubberminus-2-after-berenberg-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire &amp; Rubber -2% after Berenberg cut</a></h4><ul><li>German firm Berenberg <a href=\"https://www.barrons.com/articles/morning-movers-lululemon-soars-activision-slides-starbucks-slumps-1535720267\" target=\"_blank\">downgrades</a> Goodyear Tire &amp; Rubber (NYSE:<a href='https://seekingalpha.com/symbol/GT' title='Goodyear Tire & Rubber Co.'>GT</a>) to a Hold rating after having the tire stock set at Buy.</li><li>The Berenberg concern is that the new increasing supply of premium tires will leave the tire market significantly oversupplied in the medium term.</li><li>Shares of Goodyear are&nbsp;<font color='red'>down 2.2%</font>&nbsp;in early trading.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387164\" data-linked=\"Goodyear Tire &amp; Rubber -2% after Berenberg cut\" data-tweet=\"$GT - Goodyear Tire &amp; Rubber -2% after Berenberg cut https://seekingalpha.com/news/3387164-goodyear-tire-rubberminus-2-after-berenberg-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3387164-goodyear-tire-rubberminus-2-after-berenberg-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387148\" data-ts=\"1535719266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVA\" target=\"_blank\">DVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387148-california-bill-limiting-premium-assistance-for-dialysis-patients-passes-senate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">California bill limiting premium assistance for dialysis patients passes Senate</a></h4><ul><li>Dialysis clinic operators DaVita (NYSE:<a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a>) and American Renal Associates (NYSE:<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings'>ARA</a>) may be under pressure today on the news that a bill in California limiting reimbursement premium assistance through charitable organizations connected to/funded by companies providing the services has passed the State Senate, clearing the final hurdle for Gov. Jerry Brown's signature.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3386758-davita-ara-premarket-looming-ca-bill-curb-dialysis-premium-assistance\" target=\"_blank\">DaVita and ARA down premarket on looming CA bill to curb dialysis premium assistance</a> (Aug. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387148\" data-linked=\"California bill limiting premium assistance for dialysis patients passes Senate\" data-tweet=\"$DVA $DVA $ARA - California bill limiting premium assistance for dialysis patients passes Senate https://seekingalpha.com/news/3387148-california-bill-limiting-premium-assistance-for-dialysis-patients-passes-senate?source=tweet\" data-url=\"https://seekingalpha.com/news/3387148-california-bill-limiting-premium-assistance-for-dialysis-patients-passes-senate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387134\" data-ts=\"1535717420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387134-lululemon-starts-off-strong-in-asia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon starts off strong in Asia</a></h4><ul><li>Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) is&nbsp;<font color='green'>up 10.4%</font>&nbsp;in premarket trading after posting sizzling growth numbers in Q2.</li><li>Some of the good news coming out of the company was the early strength of the brand in Asia.</li><li>\"Our combined comps in Asia increased 50% this quarter as we continue to build momentum in the region. And importantly, in China, our e-commerce business continues to lead the way with a comp increase of over 200%,\" noted Lululemon Chief Operating Officer Stuart Haselden during the earnings call.</li><li>Lululemon also pointed to the launch of its WeChat store in China in Q2 and e-commerce plans for Korea and Japan later this year.</li><li>\"We have an aggressive plan for how digital will lead us into the future in China,\" said Lululemon exec Celeste Burgoyne added on the call.</li><li><a href=\"https://seekingalpha.com/article/4203306-lululemon-athletica-inc-lulu-ceo-calvin-mcdonald-q2-2018-results-earnings-call-transcript?part=single\" target=\"_blank\">LULU earnings call transcript</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3386995-lululemon-plus-7_3-percent-higher-margins-drive-beat-raise\" target=\"_blank\">Lululemon +7.3% as higher margins drive beat-and-raise</a> (Aug. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387134\" data-linked=\"Lululemon starts off strong in Asia\" data-tweet=\"$LULU - Lululemon starts off strong in Asia https://seekingalpha.com/news/3387134-lululemon-starts-off-strong-in-asia?source=tweet\" data-url=\"https://seekingalpha.com/news/3387134-lululemon-starts-off-strong-in-asia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387130\" data-ts=\"1535717091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387130-analysts-lower-ambarella-targets-after-weak-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts lower Ambarella targets after weak guidance</a></h4><ul><li>        Bank of America Merrill Lynch <a href=\"https://www.streetinsider.com/Analyst+Comments/BofAMerrill+Lynch+Downgrades+Ambarella+%28AMBA%29+to+Underperform/14566633.html\" target=\"_blank\">downgrades</a> Ambarella (NASDAQ:<a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a>) from Neutral to Underperform and lowers its target from $42 to $35, a 12% downside to yesterday&rsquo;s close.</li><li>               Analyst Adam Gonzalez sees trouble remaining for the legacy transition and expects muted near-term growth.&nbsp;</li><li>               More action: Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Ambarella+%28AMBA%29+PT+Lowered+to+%2450+at+Morgan+Stanley/14566806.html\" target=\"_blank\">maintains</a> an Overweight rating on Ambarella but lowers the target $8 to $50.&nbsp;</li><li>               Ambarella&nbsp;<font color='red'>drops 13.8%</font>&nbsp;premarket to $34.25.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387008-ambarella-minus-11_5-percent-weak-q3-revenue-guide\" target=\"_blank\">Ambarella -11.5% after weak Q3 revenue guide</a> (Aug. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387130\" data-linked=\"Analysts lower Ambarella targets after weak guidance\" data-tweet=\"$AMBA - Analysts lower Ambarella targets after weak guidance https://seekingalpha.com/news/3387130-analysts-lower-ambarella-targets-after-weak-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3387130-analysts-lower-ambarella-targets-after-weak-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387122\" data-ts=\"1535715684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387122-bofaml-steps-to-sidelines-on-activision-blizzard\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML steps to sidelines on Activision Blizzard</a></h4><ul><li>        Bank of America Merrill Lynch <a href=\"https://www.streetinsider.com/Analyst+PT+Change/BofAMerrill+Lynch+Downgrades+Activision+Blizzard+%28ATVI%29+to+Neutral/14566686.html\" target=\"_blank\">downgrades</a> Activision Blizzard (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>) from Buy to Neutral and lowers the price target from $84 to $77, a 4% upside to yesterday&rsquo;s close.</li><li>               Activision Blizzard shares are&nbsp;<font color='red'>down 1.9%</font>&nbsp;premarket to $72.72.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3386880-ea-minus-7_7-percent-bookings-cut-peers-hold-steady\" target=\"_blank\">EA -7.7% after bookings cut, while peers hold steady</a> (Aug. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387122\" data-linked=\"BofAML steps to sidelines on Activision Blizzard\" data-tweet=\"$ATVI - BofAML steps to sidelines on Activision Blizzard https://seekingalpha.com/news/3387122-bofaml-steps-to-sidelines-on-activision-blizzard?source=tweet\" data-url=\"https://seekingalpha.com/news/3387122-bofaml-steps-to-sidelines-on-activision-blizzard\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387117\" data-ts=\"1535715203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDTI\" target=\"_blank\">IDTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387117-nar-renesas-wants-to-buy-idt-for-over-6b-renesas-confirms-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NAR: Renesas wants to buy IDT for over $6B; Renesas confirms interest</a></h4><ul><li>Integrated Device Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a>)&nbsp;<font color='green'>gains 15%</font>&nbsp;premarket to $43.50 after <a href=\"https://asia.nikkei.com/Business/Business-Deals/Renesas-chases-6bn-deal-for-IDT-to-enhance-self-driving-chips\" target=\"_blank\">Nikkei Asian Review</a> sources say Renesas Electronics wants to acquire IDT in an over $6B deal.</li><li>Sources say the companies are in final talks and will meet at the beginning of next week, though the prospects of striking a deal &ldquo;remain unclear.&rdquo;</li><li>Renesas will fund the deal out of its cash reserves, which totaled about $1.17B at the end of June, and bank loans.</li><li>Renesas is the second-largest automotive chip producer in the world and wants IDT&rsquo;s tech to boost self-driving vehicle systems.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331535-nar-maxim-still-renesas-acquisition-shortlist\" target=\"_blank\">NAR: Maxim still on Renesas acquisition shortlist</a> (Feb. 15)</li><li>Update: Renesas <a href=\"https://www.renesas.com/us/en/about/press-center/notices/2018/notice20180831.html\" target=\"_blank\">confirms</a> its interest but provides no further details.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387117\" data-linked=\"NAR: Renesas wants to buy IDT for over $6B; Renesas confirms interest\" data-tweet=\"$IDTI - NAR: Renesas wants to buy IDT for over $6B; Renesas confirms interest https://seekingalpha.com/news/3387117-nar-renesas-wants-to-buy-idt-for-over-6b-renesas-confirms-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3387117-nar-renesas-wants-to-buy-idt-for-over-6b-renesas-confirms-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387112\" data-ts=\"1535714217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387112-virnetxplus-35_6-after-judge-denies-apple-new-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX +35.6% after judge denies Apple a new trial</a></h4><ul><li>VirnetX (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a>) holdings are&nbsp;<font color='green'>up 35.6%</font>&nbsp;to $4 premarket after a federal judge denies Apple&rsquo;s motion for a new trial in the patent dispute.</li><li>The district court judge denied the motion on certain merits of VirnetX&rsquo;s case then denied-in-part and granted-in-part VHC&rsquo;s motion for entry of judgment and for equitable and statutory relief.</li><li>In April, a judge found Apple had infringed on four VirnetX patents. The jury told Apple to pay $502.6M in damages.</li><li>VirnetX sued Apple in 2010 with the fight centering around the company&rsquo;s VPN on Demand tech and FaceTime and iMessage software and services.</li><li>Source: <a href=\"https://appleinsider.com/articles/18/08/30/apple-loses-bid-for-new-trial-in-virnetx-case-appeal-still-be-possible\" target=\"_blank\">AppleInsider</a>.</li><li>Update: VHC <a href=\"https://seekingalpha.com/pr/17258529-virnetx-receives-district-courts-final-judgment-affirming-jurys-verdict-502_6-million\" target=\"_blank\">confirms</a> the court's decision.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387112\" data-linked=\"VirnetX +35.6% after judge denies Apple a new trial\" data-tweet=\"$VHC - VirnetX +35.6% after judge denies Apple a new trial https://seekingalpha.com/news/3387112-virnetxplus-35_6-after-judge-denies-apple-new-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/3387112-virnetxplus-35_6-after-judge-denies-apple-new-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387107\" data-ts=\"1535713809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387107-astrazenecas-anifrolumab-flunks-late-stage-lupus-study-shares-down-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca&#39;s anifrolumab flunks late-stage lupus study; shares down 1% premarket</a></h4><ul><li>AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>) slips&nbsp;<font color='red'>1%</font>&nbsp;premarket on light volume in response to its <a href=\"https://www.astrazeneca.com/media-centre/press-releases/2018/update-on-tulip-1-phase-iii-trial-for-anifrolumab-in-systemic-lupus-erythematosus-31082018.html\" target=\"_blank\">announcement </a>that a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02547922?titles=tulip+1&amp;lead=astrazeneca&amp;rank=1\" target=\"_blank\">TULIP 1</a>, evaluating anifrolumab in adult patients with moderate-to-severe systemic lupus erythematosus &#40;SLE&#41; failed to achieve the primary endpoint of a statistically valid reduction in disease activity at month 12 as measured by a scale called SRI4.</li><li>Detailed data will be submitted for presentation at a future medical conference.</li><li>Anifrolumab (formerly MEDI-546) is a fully human monoclonal antibody that targets the type 1 interferon &#40;IFN&#41; receptor that inhibits the activity of all type 1 IFNs which play a key role in SLE. The company was counting on it to be one of its top growth drivers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2916356-astrazenecas-anifrolumab-successful-mid-stage-lupus-study\" target=\"_blank\">AstraZeneca's anifrolumab successful in mid-stage lupus study</a> (Nov. 10, 2015)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387107\" data-linked=\"AstraZeneca&#39;s anifrolumab flunks late-stage lupus study; shares down 1% premarket\" data-tweet=\"$AZN - AstraZeneca&#39;s anifrolumab flunks late-stage lupus study; shares down 1% premarket https://seekingalpha.com/news/3387107-astrazenecas-anifrolumab-flunks-late-stage-lupus-study-shares-down-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3387107-astrazenecas-anifrolumab-flunks-late-stage-lupus-study-shares-down-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387094\" data-ts=\"1535710781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIG\" target=\"_blank\">BIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387094-big-lotsminus-5_77-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BIG Lots -5.77% on earnings miss</a></h4><ul><li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) reports comparable-store sales rose 1.6% in <a href=\"https://seekingalpha.com/pr/17258347-big-lots-announces-quarterly-dividend-common-stock\" target=\"_blank\">Q2</a>, meets guidance of&nbsp;flat to +2%.</li><li>Gross margin rate slipped 20 bps to 40.2%.</li><li>SG&amp;A expense rate grew 90 bps to 34.9%.</li><li>Operating margin rate fell 110 bps to 2.8%.</li><li>Inventory +5.4% Y/Y to $854.2M.</li><li><b>Q3 Guidanc</b>e:&nbsp;Comparable-store sales:&nbsp;+2% to +4%;&nbsp;Adjusted&nbsp;EPS: -$0.06 to $0.04.</li><li><b>Q4 Guidanc</b>e:&nbsp;Comparable-store sales:&nbsp;increase in the low single digit range;&nbsp;Adjusted&nbsp;EPS: $2.9 to $3.</li><li><b>FY2018 Guidance</b>: Comparable-store sales: ~+1%; Adjusted&nbsp;EPS:&nbsp;$4.40 to $4.55 (+7% to +11%); Cash flow: $100M to $110M.</li><li>BIG&nbsp;<font color='red'>-5.77%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387090-big-lots-misses-0_08-misses-revenue\" target=\"_blank\">Big Lots misses by $0.08, misses on revenue</a> (Aug. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3387094\" data-linked=\"BIG Lots -5.77% on earnings miss\" data-tweet=\"$BIG - BIG Lots -5.77% on earnings miss https://seekingalpha.com/news/3387094-big-lotsminus-5_77-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3387094-big-lotsminus-5_77-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3387067\" data-ts=\"1535698960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCEHY\" target=\"_blank\">TCEHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3387067-china-tightens-grip-on-gaming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China tightens grip on gaming</a></h4><ul><li>As part of plan to combat vision problems and other ills, the Chinese government is <a href=\"https://www.wsj.com/articles/chinese-videogame-companies-shudder-as-government-tightens-grip-1535690686\" target=\"_blank\">tightening</a> its control over videogames, including restricting the number of online games and limiting play time for children,.</li><li>The clampdown, which sent shares of Tencent (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holding Ltd. ADR'>OTCPK:TCEHY</a>) and NetEase (NASDAQ:<a href='https://seekingalpha.com/symbol/NTES' title='NetEase, Inc'>NTES</a>) <font color='red'>down as much as 7%</font>, builds on a wider campaign against online content that started in March when Chinese regulators froze sales of new game releases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3387067\" data-linked=\"China tightens grip on gaming\" data-tweet=\"$TCEHY $TCEHY $NTES - China tightens grip on gaming https://seekingalpha.com/news/3387067-china-tightens-grip-on-gaming?source=tweet\" data-url=\"https://seekingalpha.com/news/3387067-china-tightens-grip-on-gaming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":52,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}